These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 113377)

  • 21. Clavulanic acid, a novel inhibitor of beta-lactamases.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Nov; 14(5):650-5. PubMed ID: 310279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combinations of mezlocillin with other antibiotics. A review of in vitro laboratory studies (author's transl)].
    Courtieu AL; Billaudel S; Drugeon HB; Chung SS
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):329-31. PubMed ID: 6460970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.
    Miller JM; Baker CN; Thornsberry C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):794-6. PubMed ID: 103496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N; Neu HC
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R; Puppel H
    Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Labbé M; Crokaert F
    J Antimicrob Chemother; 1981 Sep; 8(3):219-24. PubMed ID: 6457023
    [No Abstract]   [Full Text] [Related]  

  • 28. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.
    Romagnoli MF; Fu KP; Neu HC
    J Antimicrob Chemother; 1980 Sep; 6(5):601-6. PubMed ID: 6967870
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility of cefoxitin-resistant isolates of bacteroides to other agents including beta-lactamase inhibitor/beta-lactam combinations.
    Cherubin CE; Appleman MD
    J Antimicrob Chemother; 1993 Jul; 32(1):168-71. PubMed ID: 8226410
    [No Abstract]   [Full Text] [Related]  

  • 31. Proposed mezlocillin disk control values for staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853.
    Prior RB; Fass RJ
    Am J Clin Pathol; 1982 Mar; 77(3):332-3. PubMed ID: 6462053
    [No Abstract]   [Full Text] [Related]  

  • 32. A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studies.
    Barry AL; Jones RN
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():35-45. PubMed ID: 6804432
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 34. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria.
    Okubadejo OA; Allen J
    J Antimicrob Chemother; 1975 Dec; 1(4):403-9. PubMed ID: 812858
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro antibiotic activity of 11 beta-lactam antibiotics in a cancer center.
    Landoy Z; Roisilin C; Surgalla MJ; Botzer R; Fitzpatrick JE; Blumenson LE
    J Surg Oncol; 1985 Sep; 30(1):23-5. PubMed ID: 3935872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae.
    Zhou XY; Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1993 Apr; 31(4):473-80. PubMed ID: 8514645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S; Gupta A; Thadepalli H
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.
    Sanders CC; Sanders WE
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
    Hedberg M; Edlund C; Lindqvist L; Rylander M; Nord CE
    J Antimicrob Chemother; 1992 Feb; 29(2):105-13. PubMed ID: 1506324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.